Schedule 13G ownership disclosure

Skye Bioscience, Inc.

Security class unavailable · CUSIP: 83086J101

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,000,000
Percent of class
0.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-22-000045
Form type
SC 13G/A
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Jan 05, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub